Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK/ERK signaling pathway in vitro. by Gao, Wei et al.
UC Davis
UC Davis Previously Published Works
Title
Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK/ERK 
signaling pathway in vitro.
Permalink
https://escholarship.org/uc/item/0tk6738p
Journal
PloS one, 9(11)
ISSN
1932-6203
Authors
Gao, Wei
Zhou, Ping
Ma, Xiaocui
et al.
Publication Date
2014
DOI
10.1371/journal.pone.0112698
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Ethanol Negatively Regulates Hepatic Differentiation of
hESC by Inhibition of the MAPK/ERK Signaling Pathway
In Vitro
Wei Gao1,2,3., Ping Zhou2,3*., Xiaocui Ma2,3, Benjamin Tschudy-Seney2,3, Jiamei Chen2,3,5,
Nataly L. Magner2,3, Alexander Revzin4, Jan A. Nolta2,3, Mark A. Zern2,3, Yuyou Duan2,3*
1Department of Biomedical Engineering, College of Biology, Hunan University, Changsha, Hunan, China, 2Department of Internal Medicine, University of California Davis
Medical Center, Sacramento, California, United States of America, 3 Institute for Regenerative Cures, University of California Davis Medical Center, Sacramento, California,
United States of America, 4Department of Biomedical Engineering, University of California Davis, Davis, California, United States of America, 5 Institute of Liver Diseases,
Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Abstract
Background: Alcohol insult triggers complex events in the liver, promoting fibrogenic/inflammatory signals and in more
advanced cases, aberrant matrix deposition. It is well accepted that the regenerative capacity of the adult liver is impaired
during alcohol injury. The liver progenitor/stem cells have been shown to play an important role in liver regeneration -in
response to various chronic injuries; however, the effects of alcohol on stem cell differentiation in the liver are not well
understood.
Methods: We employed hepatic progenitor cells derived from hESCs to study the impact of ethanol on hepatocyte
differentiation by exposure of these progenitor cells to ethanol during hepatocyte differentiation.
Results: We found that ethanol negatively regulated hepatic differentiation of hESC-derived hepatic progenitor cells in a
dose-dependent manner. There was also a moderate cell cycle arrest at G1/S checkpoint in the ethanol treated cells, which
is associated with a reduced level of cyclin D1 in these cells. Ethanol treatment specifically inhibited the activation of the ERK
but not JNK nor the p38 MAP signaling pathway. At the same time, the WNT signaling pathway was also reduced in the cells
exposed to ethanol. Upon evaluating the effects of the inhibitors of these two signaling pathways, we determined that the
Erk inhibitor replicated the effects of ethanol on the hepatocyte differentiation and attenuated the WNT/b-catenin signaling,
however, inhibitors of WNT only partially replicated the effects of ethanol on the hepatocyte differentiation.
Conclusion: Our results demonstrated that ethanol negatively regulated hepatic differentiation of hESC-derived hepatic
progenitors through inhibiting the MAPK/ERK signaling pathway, and subsequently attenuating the WNT signaling
pathway. Thus, our finding provides a novel insight into the mechanism by which alcohol regulates cell fate selection of
hESC-derived hepatic progenitor cells, and the identified pathways may provide therapeutic targets aimed at promoting
liver repair and regeneration during alcoholic injury.
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Introduction
The liver is the major location for the metabolism of ethanol,
and alcoholic hepatitis and other forms of alcoholic liver disease
(ALD) are major complications of chronic excessive ethanol intake
[1,2]. At an early stage in the course of alcohol-induced liver
injury, damaged hepatocytes can be replaced by the proliferation
of adult hepatocytes. However, with the course of more
progressive and chronic injury, hepatocyte proliferation becomes
less successful in the re-establishment of an adequate hepatocyte
mass for the restoration of liver function. At that stage, the
differentiation of hepatic stem/progenitor cells becomes critical in
hepatocyte regeneration and in the other elements of the repair
process, including fibrogenesis. Although the types and nomen-
clature of liver stem/progenitor cells are in some dispute, and
differ in rodents and humans, there is some consensus that they
evolve from bipotent stem cells that resides within the Canal of the
Hering between the hepatocyte plate and bile duct. These liver
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stem/progenitor cells are shown to give rise to both hepatocytes
and cholangiocytes in response to various chronic injuries [3,4].
The effects of alcohol injury of adult liver cells have been
studied extensively. Alcohol injures hepatocytes and activates
stellate cells as well as Kupffer cells, leading to a loss of hepatic
function, aberrant deposition of ECM proteins and production of
inflammatory and profibrogenic signals [5,6,7,8]. However,
relatively little is known about the human liver stem cell response
to this toxicant [9]. While the isolation of human hepatic
progenitor cells has been reported in the literature [10,11,12],
the scarcity of human livers and small numbers of progenitor/stem
cells in the liver make it impractical to conduct mechanistic studies
of alcoholic injury on liver progenitor/stem cells in vivo. Thus,
other approaches must be made to employ an appropriate in vitro
model to evaluate the impact of alcohol on liver progenitor/stem
cells. Hepatic derivatives from human embryonic stem cells
(hESCs) provide promising resources to acquire knowledge of the
cellular and molecular bases underlying human liver development
and pathological conditions. A recent report evaluated ethanol
treatment during the middle and late stages of hepatic differen-
tiation from hESCs, thus mimicking how alcohol may cause liver
damage in vivo using an in vitro model employing hESCs [13].
We employed hESCs to progressively differentiate them into
definitive endoderm (DE) cells, then hepatic progenitor cells, and
finally hepatocytes [14,15,16,17,18,19,20,21]. Thus, hESC-de-
rived hepatic progenitor cells after the DE stage can be used as an
alternative to bioptent liver progenitor/stem cells, In the present
study, we treated the hESC-derived hepatic progenitor cells with
ethanol immediately after the DE stage, and evaluated the effects
of ethanol on early hepatic differentiation with an attempt to
mimic how alcohol modulates the differentiation of hepatic
progenitor cells in vivo using this in vitro model employing hESC.
We further investigated the mechanism by which ethanol
modulated the hepatic differentiation from these hepatic progen-
itor cells.
Materials and Methods
Cell culture
The human embryonic stem cells (hESC), H9 line, was
purchased from WiCell Research Institute (Madison, WI), and
maintained and expanded on mouse embryonic fibroblasts (MEFs)
as instructed by the provider.
Differentiation of hESC towards hepatocytes
Hepatocyte differentiation started from the induction of
definitive endoderm (DE) from hESCs using previously described
protocols [21]. Briefly, hESCs was induced to DE in RPMI
medium (Invitrogen) with 100 ng/ml activin A (R & D Systems
Inc.) without serum for 2 days and then the medium was changed
to RPMI medium with 100 ng/ml activin A, 0.5 mM sodium
butyrate and 16B27 supplement (Invitrogen) for 6 days. DE cells
were then split and re-seeded on collagen I-coated 6-well plates
(BD) in IMDM media (Invitrogen) supplemented with 20% FBS
(Invitrogen), FGF-4 (20 ng/ml), HGF (20 ng/ml), BMP2 (10 ng/
ml), BMP4 (10 ng/ml) (R and D), 0.3 mM 1-thioglycerol (Sigma),
0.5% DMSO (Sigma), 100 nM dexamethasone (Sigma) and
0.126 U/ml human insulin (Hospira, Inc) for 2 weeks. Then the
cells were further differentiated and maturated in hepatocyte
culture medium supplemented with SingleQuots (Lonza), 0.5%
DMSO, 100 nM dexamethasone, 20 ng/ml FGF4, 20 ng/ml
HGF, and 50 ng/ml oncostatin M (R & D systems) until use.
Treatment of differentiated cells with ethanol
Ethanol was used to treat the differentiating cells daily at day 2
after the DE cells were re-seeded on collagen I-coated plates for
differentiation to hepatocytes at three concentrations of 25 mM,
50 mM, and 100 mM until use.
Immunohistochemistry
Differentiated cells were fixed with 4% paraformaldehyde and
analyzed by immunohistochemistry as described previously by us
[21]. Antibodies used are listed in Table S1.
MTT viability assay
MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bro-
mide) (Sigma-Aldrich) was added to the cell cultures at the final
concentration of 0.5 mg/ml. Culture media was aspirated 3–4 h
later. The products of MTT were dissolved in DMSO and
measured for absorbance at 570 nm.
Quantitative RT-PCR (qRT-PCR)
Differentiated cells were harvested at different time points after
differentiation, and total RNA isolation, cDNA generation and
quantitative real-time PCR were carried out as previously
described [21]. Primers or primers/probes used are listed in
Table S2.
Western Blot Analysis
Differentiated cells were lysed in RIPA buffer with proteinase
inhibitor cocktail and 5 mM EDTA (Thermo Fisher Scientific) at
different time points after differentiation. 30–50 mg of total
proteins or 5–10 mg of nuclear protein was used for immunoblot
analysis as previously described [22]. Antibodies used are listed in
Table S1.
Enzyme-Linked Immunosorbent Assay analysis
The enzyme-linked immunosorbent assay (ELISA) was used to
determine human ALB values secreted into the medium by
differentiated cells. ELISA analysis was performed as previously
described [21].
Small Molecule Inhibitors
U0126 (Erk inhibitor, EMD4Biosciences) and IWR-1-endo
(WNT1 inhibitor, Tocris), were dissolved in DMSO and used at
the concentration of 10 and 0.2 mM, respectively from day 2 after
differentiation until use.
Rescue of impaired hepatocyte differentiation
Rescue of impaired hepatocyte differentiation was performed by
supplementing high dose FGF-4 or HGF at the range of 40 ng/ml
to 100 ng/ml in the presence of U0126 at the concentration of
10 mM.
Flow cytometry for cell cycle analysis
The differentiated cells treated with or without ethanol were
harvested, permeabilized, fixed in ethanol. Prior to the staining,
the cells were treated with RNase A to remove RNAs from the
cells. Then propidium iodide staining and flow cytometry was
performed for cell cycle analysis as described [23,24].
PCR Array assay
Differentiated cells were harvested at different time points after
differentiation, and total RNA isolation, cDNAs were generated
using RT2 First Strand Kit (Qiagen), Signal Transduction
PathwayFinder PCR Array (PAHS-014Z, Sabiosciences) was
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Figure 1. Effects of ethanol on the differentiation of hESC towards hepatocytes. (A) Schematic illustration of the differentiation protocol
and the time frame of ethanol treatment. (B) Immunostaining of albumin in the hESC-derived hepatocytes (hEH) at day 24 exposed to the indicated
doses of ethanol (x100). (C) Cell viability was assessed at day 24 by MTT assay. (D, E) qPCR was performed to determine the expression of liver genes,
ALB and ASGPR1, C/EBPa, and HNF1a at day 24 exposed to the indicated doses of ethanol. (F) Secreted ALB levels in the culture media by hEH were
assessed by ELISA at day 24 with or without ethanol treatment. (G) Dynamic expression changes of metabolizing enzymes, CYP3A4, CYP7A1, and
UTG1A6 in hEH were evaluated by qPCR at different time points after differentiation in the presence or absence of ethanol at 100 mM. (*p,0.05 vs.
no EtOH; #p,0.005 vs. no EtOH).
doi:10.1371/journal.pone.0112698.g001
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performed using RT2 SYBR Green qPCR Mastermix (Sabios-
ciences), and data was analyzed as instructed by the provider. The
84 genes used in PCR Array are listed in Figure S1.
Statistics
All data were summarized as means 6 SEM from at least three
independent measurements. An unpaired Student t test was used
to analyze the data. p,0.05 was considered statistically significant.
Results
Ethanol impaired hepatocyte differentiation from hESC-
derived hepatic progenitor cells
We employed our previously developed protocol to progres-
sively differentiate hESCs to definitive endoderm (DE), hepatic
progenitor cells and hESC-derived hepatocyte (hEHs) (Figure 1A)
[21]. The differentiating cells after the DE stage were treated daily
with ethanol at three final concentrations, 25 mM, 50 mM,
100 mM. Cells not exposed to ethanol were used as a control. We
determined that exposure to ethanol resulted in a dose-dependent
decrease in the number of albumin (ALB) positive cells in the
cultures, determined by immunohistochemistry (Figure 1B). The
reduced number of ALB expressing cells was not due to the toxic
effect of ethanol on these cells because ethanol, even at 100 mM,
did not significantly alter the viability of the cells as determined by
the MTT assay (Figure 1C). Consistent with the decreased
number of ALB positive cells in the ethanol-treated cultures, the
expression level of albumin and another marker of a mature
hepatic phenotype, asialoglycoprotein receptor 1 (ASGPR1), as
determined by qRT-PCR, was also markedly reduced in the cells
treated with 50 or 100 mM ethanol (Figure 1D). Liver specific
Figure 2. Effects of ethanol on cell proliferation. (A, B) Flow cytometry to assess the amount of DNA in the G1, S, and G2 phases during the cell
cycle at day 8 after differentiation in the presence or absence of ethanol at 100 mM. (C) qPCR was performed to evaluate the expression of cyclin D1
at days 4 and 8 after differentiation in the presence or absence of ethanol at 100 mM (*p,0.05 vs. no EtOH). (D) Western blot analysis was used to
determine protein expression of albumin (ALB), and cyclin D1 at day 8 after differentiation in the presence or absence of ethanol at 100 mM. GAPGH
was used as housekeeping gene control.
doi:10.1371/journal.pone.0112698.g002
Figure 3. Expression of ethanol metabolizing genes during
hepatocyte differentiation of hESC. qRT-PCR was employed to
evaluate the dynamic expression of alcohol dehydrogenases (ADHs),
ADH1A, ADH1B and ADH4, and by aldehyde dehydrogenases (ALDH),
ALDH2 during the hepatocyte differentiation from ESC-derived hepatic
progenitor cells.
doi:10.1371/journal.pone.0112698.g003
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transcription factor C/EBPa has been shown to play an important
role in hepatocyte differentiation, and it was significantly reduced
by ethanol at all tested concentrations as assessed by qRT-PCR,
whereas the expression of HNF1a was markedly down-regulated
by the ethanol treatment at 100 mM (Figure 1E). A functional
assay also showed that the amount of secreted albumin was
Figure 4. Effects of U0126, Erk inhibitor, on the differentiation of hESC towards hepatocytes. (A) Western blot analysis was employed to
determine the effect of ethanol on the MAPK signaling pathway at day 8 after differentiation in the presence or absence of ethanol at 100 mM. (B)
qPCR was used to determine the expression of albumin (ALB), CYP3A4 (3A4), b-catenin (b-cat), and cyclin D1 (D1) at day 8 after differentiation in the
presence or absence of U0126 at 10 mM (*p,0.05 vs. no inhibitor; #p,0.005 vs. no inhibitor). (C) qPCR and ELISA were employed to evaluate the
relative expression levels of albumin (ALB) and secreted ALB into the medium in the same samples in the presence or absence of U0126 at 10 mM.
(p,0.05 vs. no inhibitor). (D–G) Western blot analysis was performed to determine protein expression of albumin (ALB), phosphorylated Erk (p-ERK),
phosphorylated GSK-3b at the Ser9 residue (p-GSK3b), and cyclin D1 cytoplasm, and b-catenin in nucleus at day 8 after differentiation in the presence
or absence of U0126 at 10 mM. GAPDH and a-Tubulin were control housekeeping genes in cytoplasm and nucleus. (H) Western blot analysis was used
to evaluate the expression of albumin (ALB), and cyclin D1 by supplementing high dose FGF-4 (F) or HGF (H) at day 8 after differentiation in the
presence or absence of U0126 at 10 mM.
doi:10.1371/journal.pone.0112698.g004
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markedly reduced by ethanol in a dose-dependent manner
(Figure 1F). Metabolism and detoxification are important function
of hepatocytes, in which cytochrome P450 (CYP) and UGT play
key roles. We evaluated several important phase I and II
metabolizing enzymes in the cells treated with ethanol at
100 mM, and found that the expression of CYP3A4, CYP7A1,
and UGT1A6, was significantly reduced by ethanol (Figure 1G).
Therefore, our results demonstrated that hepatocyte differentia-
tion from hESC-derived hepatic progenitor cells was markedly
impaired by exposure to ethanol.
Ethanol induced a moderate growth arrest in hESC-
derived hepatic progenitor cells
To assess the effect of ethanol on the proliferation of the hESC-
derived hepatic progenitor cells, these progenitor cells were
exposed to ethanol for 8 days, and their cell cycle distribution
was determined by flow cytometry. Ethanol treatment increased
the population in G1 phase and reduced the population in S phase
(Figure 2B) compared to the control cells (Figure 2A), suggesting
that a cell cycle arrest at G1/S phase was induced in ethanol-
exposed cells. Since G1/S transition is controlled by CDK4/6-
cyclin D complexes, we next assessed the level of cyclin D1 in the
progenitor cells with or without ethanol treatment by qPCR and
Western blot. Consistent with the G1/S phase arrest, the level of
cyclin D in ethanol exposed cells was reduced (Figure 2C and D).
Thus, ethanol induced a moderate growth arrest at the G/S phase
in hESC-derived hepatic progenitor cells associated with a
decreased cyclin D 1 expression.
Several alcohol metabolizing enzymes were up-regulated
during hepatocyte differentiation
Ethanol is metabolized first to acetaldehyde primarily by
alcohol dehydrogenases (ADHs) and the cytochrome p450 family
protein CYP2E1 [25]. Acetaldehyde is toxic to cells by inducing
oxidative stress in the liver, and can be further converted into
acetate by aldehyde dehydrogenases (ALDH) [25]. We found that
the expression of ADH1A, ADH1B and ADH4 were substantially
induced during the hepatocyte differentiation from hESC-derived
hepatic progenitor cells (Figure 3). The expression of ALDH2 was
induced very early at DE stage and the elevated level was
maintained during the remainder of hepatocyte differentiation
(Figure 3). Thus, our data suggest that hepatocyte progenitor cells
derived from hESCs have the capacity to metabolize ethanol.
Ethanol inhibited the ERK MAPK signaling pathway
The PI3 K/AKT and MAPK signaling pathways have been
shown to be involved in early liver development and hepatic
differentiation [26,27,28]. In order to investigate how ethanol
alters hepatic differentiation at the molecular level, we assessed the
effect of ethanol on the activation of the PI3 K/AKT and MAPK
Figure 5. Effects of IWR-1-endo, a WNT1 inhibitor, on the differentiation of hESC towards hepatocytes. (A) The entire view of the
expression changes of 84 genes representing 10 pathways by PCR Array analysis at day 10 after differentiation in the presence or absence of ethanol
at 100 mM. The names of the 84 genes and their expression fold changes are listed in Figure S1. (B) qPCR was performed to evaluate the expression
of Wnt1 at 8 after differentiation in the presence or absence of ethanol at 100 mM (p,0.05 vs. no inhibitor). (C) Western blot analysis was used to
determine protein expression of Wnt1, phosphorylated GSK-3b at the Ser9 residue, and TCF1 in cytoplasm, and b-catenin in nucleus at day 8 after
differentiation in the presence or absence of ethanol at 100 mM. GAPGH and a-Tubulin were used to as housekeeping gene controls in the cytoplasm
and nucleus respectively. (D) qPCR was used to measure the expression of albumin (ALB), alpha fetoprotein (AFP), CYP3A4 (3A4), and TCF1 at day 8
after differentiation in the presence or absence of IWR-1-endo at 0.2 mM (#p,0.005 vs. no inhibitor). (E–G) Western blot analysis was employed to
determine protein expression of albumin (ALB), and TCF1 in cytoplasm, and b-catenin in nucleus at day 8 after differentiation in the presence or
absence of IWR-1-endo, at 0.2 mM. GAPDH and a-Tubulin as control housekeeping genes in cytoplasm and nucleus.
doi:10.1371/journal.pone.0112698.g005
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pathways. We found that exposure to ethanol resulted in reduced
activation/phosphorylation of ERK but not JNK and p38 in the
MAPK pathway, as determined by Western blot (Figure 4A). The
activation/phosphorylation of AKT was only transiently reduced
in the presence of ethanol (data not shown).
In order to further investigate whether the ERK signaling
pathway regulates hepatocyte differentiation, cells were treated
with an inhibitor of MEK1/2, U0126, at 5 or 10 uM from day 2 to
day 10 during hepatocyte differentiation of hESC-derived
progenitor cells. It is known that activated MEK1/2 specifically
catalyzes the phosphorylation of ERK1/2, and thus U0126 can
block the activation of ERK. The low concentration of U0126 was
chosen to mimic the partial inhibition of ERK activation elicited
by ethanol. Inhibition of the ERK signaling pathway markedly
decreased the expression of ALB, CYP3A4, as determined by
qPCR and Western blot (Figure 4B and D). Furthermore, a
functional assay showed that albumin secretion was also markedly
reduced by the inhibition of the ERK signaling pathway
(Figure 4E). We confirmed that the phosphorylated Erk (active
Erk) was indeed reduced by U0126 (Figure 4C). Inhibition of
ERK activation by U0126 also reduced the level of phosphory-
lated GSK-3b and nuclear b-catenin (Figure 4B, E and F),
suggesting a reduced activation of Wnt signaling pathway when
ERK activation was inhibited. Furthermore, the expression of
cyclin D1 was significantly down-regulated in the presence of
U0126, as determined by both qPCR and Western blot (Figure 4B
and G). Therefore, our results suggested that ethanol compro-
mised hepatocyte differentiation by inhibition of ERK activation.
FGF4 and HGF have been shown to promote hepatocyte
differentiation via the MAPK/ERK pathway (14, 34). Hence in
order to investigate whether impaired hepatocyte differentiation
can be rescued in the presence of the ERK inhibitor, different
doses FGF4 and HGF at 20, 40, 60, 80 and 100 ng/ml were
supplemented in the differentiation medium in the presence of
U0126. Either FGF4 or HGF at 60 ng/ml or higher restored the
expression of ALB and cyclin D1 in the cells even in the presence
of U0126 (Figure 4H), indicating that impaired hepatocyte
differentiation and proliferation was partially rescued.
Ethanol reduced the WNT signaling pathway in hESC-
derived hepatic progenitor cells
In order to investigate whether specific signaling pathways are
involved in hepatic differentiation in the presence of ethanol, the
Signal Transduction PathwayFinder PCR Array containing 84
genes representing 10 pathways was employed to assess the effects
of ethanol treatment on the progenitor cells. Four genes including
Wnt1 were found to be down-regulated by ethanol (Figure 5A,
Figure S1). Since the Wnt signaling pathway has been associated
with hepatocyte and cholangiocyte differentiation [29,30,31], we
sought to further determine whether this pathway was indeed
affected by ethanol. The reduced expression of Wnt 1 in the
ethanol- treated progenitor cells was confirmed by qPCR and
Western blots (Figure 5B and C). Phosphorylation of GSK-3b, b-
catenin nuclear translocation, and TCF1 up-regulation have been
shown to be involved in the Wnt pathways [32,33,34]. The
phosphorylation of GSK-3b is essential for de-phosphorylation of
b-catenin and release of b-catenin from the destructive complex to
translocate into the nucleus [32]. To further assess whether these
downstream Wnt signaling components are altered by ethanol, the
level of phosphorylated GSK-3b, TCF1 and nuclear b-catenin in
the progenitor cells treated with or without ethanol was
determined by Western blot analysis. We found that ethanol
markedly reduced the level of phosphorylated GSK-3b as well as
the level of TCF1 and nuclear b-catenin (Figure 5C). Thus, our
data demonstrated that the WNT pathway was attenuated during
early hepatic differentiation in the presence of ethanol.
In order to further investigate whether Wnt signaling regulates
hepatocyte differentiation from hESC-derived hepatic progenitor
cells, the Wnt inhibitor, IWR-1-endo, was used to treat cells at the
final concentration of 0.2 mM from day 2 to day 8 during the
differentiation. The expression of ALB, AFP, and CYP3A4 was
dramatically decreased by the inhibitor, as determined by qRT-
PCR and Western blot (Figure 5D and E). We determined that
IWR-1-endo indeed reduced the amount of b-catenin in the
nucleus (Figure 5F), as well as TCF1, a b-catenin target gene
(Figure 5F). Our data suggest that Wnt signaling may be required
for hepatocyte differentiation, and may also be affected by ethanol
treatment.
Discussion
In liver development, expression of mesenchymal WNT and
fibroblast growth factor 4 (FGF4) signaling in the foregut enables
liver and pancreas induction [26,35,36]; afterwards, FGF from the
cardiac mesoderm and BMP from septum transversum mesen-
chymal cells coordinately induce liver differentiation and suppress
the pancreatic differentiation [25,26,37,38,39] in the ventral
foregut. MAPK is activated in response to FGF in the lateral
hepatic progenitors [26,40]. The newly specified hepatic cells in
embryos are hepatoblasts, which express liver specific genes and
are bipotent, and these cells further differentiate into hepatocytes
and cholangiocytes [26,41]. Recent studies suggest an important
role for FGF/extracelluar signal-regualted kinase (Erk) signaling in
promoting the transition from a naı¨ve state to a primed state in
pluripotent stem cells [42,43,44,45,46]. FGF4 is the major
stimulus activating Erk in embryonic stem cells as FGF4-
stimulated activation of Erk1/2 is an autoinductive stimulus for
Figure 6. Effects of ethanol on promotion of non-hepatocyte
lineage and model for effects of ethanol. Model for effects of
ethanol on the differentiation of hESC towards hepatocytes.
doi:10.1371/journal.pone.0112698.g006
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naı¨ve ES cells to exit self-renewal, and the Erk cascade directs
transition to a state that is responsible to inductive cues for germ
layer segregation [47]. Other studies have shown that FGF4
signaling directs endoderm lineages [42]. In addition, MAPK
(JNK, p38, and Erk) signaling pathways have been shown to play
an important role in mediating stem cell proliferation and
differentiation [48,49,50]. These pathways constitute a large
kinase network that regulates a variety of physiological process,
including cell growth, differentiation, and apoptotic cell death, in
response to a diverse set of stimuli. Moreover, recent studies have
indicated that FGF4 and HGF promote the differentiation of
mouse bone marrow mesenchymal stem cells towards hepatocytes
via the MAPK (p-38 and Erk) pathway [28].
In our differentiation conditions, FGF4, HGF, BMP2 and
BMP4 were employed to induce early hepatic differentiation [21],
mimicking in vivo liver development. Importantly, we determined
that ethanol inhibited hepatocyte differentiation form hESC-
derived hepatic progenitor cells and Erk activation was attenuated
by the treatment with ethanol, indicating that the activation of Erk
appears to be a critical pathway which directs the hepatic
progenitors to differentiate towards hepatocytes under our
differentiation condition (Figure 4A). We further revealed that
inhibition of Erk activity by ethanol resulted in the inhibition of
the phosphorylation of GSK-3b at the Ser9 residue, which in turn
decreased the translocation of b-catenin into the nucleus.
Consistent with the reduced WNT signaling, the expression of
b-catenin target genes, TCF1 and cyclin D1, was also down-
regulated in ethanol exposed cells. The reduced level of cyclin D in
these cells led to a moderate cell cycle arrest at G1/S checkpoint.
This pathway was confirmed by employing the Erk inhibitor,
U0126and the level of p-Erk and p-GSK-3b, nuclear b-catenin,
and cyclin D1 was significantly decreased in the presence of
U0126 (Figure 4). Similar to ethanol treatment, the Erk inhibitor
also markedly reduced the expression of many liver specific genes
and the secretion of ALB (Figure 4). The expression of albumin
and cyclin D1 in cells exposed to U0126 could be partially rescued
by excess doses of FGF4 or HGF (Figure 4H). We have shown
previously that FGF4 and HGF potently activates ERK, JNK and
p38 MAPK pathways in hESC-derived hepatic progenitor cells
[27]. Here, our data suggest that the ERK pathway is the major
signaling pathway by which FGF4 and HGF function during
hepatocyte differentiation.
The WNT signaling pathway has been also implicated during
the onset of hepatic development, however, the contribution of this
signaling is complex [29]. WNT signaling initially inhibits liver
induction [34] but shortly afterwards promotes liver bud growth
and differentiation [26,35,51,52]. In studies of Xenopus, at early
somite stages, WNT signaling acts in the posterior endoderm to
repress expression of Hhex, an essential transcriptional regulator
of hepatic development. If WNT signaling is blocked in the
posterior endoderm, it results in ectopic liver development.
Repression of WNT signaling by expression of WNT antagonists
in the anterior endoderm is required to relieve repression of Hhex
in the anterior endoderm and so facilitate commitment of the
endoderm to a hepatic fate. In contract to the repressive effects of
WNTs at early somite stages, following specification, WNT
signaling appears to promote hepatogenesis in multiple systems
including xenopus [35], and Zebrafish [29,52,53]. Studies in
rodents elucidated the role of wnt1 in directing oval cells (hepatic
stem cells in rodents) to differentiate to hepatocytes during the liver
regeneration induced by 2-acetylaminofluorene and partial
hepatectomy liver regeneration in the rat [30]. Inhibition of
WNT1 resulted in failure of hepatocyte differentiation from oval
cells, but enhanced cholangiocyte differentiation from oval cells
leading to atypical ductular hyperplasia [30]. In our study, WNT1
was significantly down-regulated by ethanol treatment (Figure 2
and 5), and expression of b-catenin and TCF1 was also reduced,
suggesting that MAPK/ERK and WNT/b-catenin pathways were
synergistically involved in negatively affecting early hepatic
differentiation of hESC during EtOH treatment. When we
employed the WNT1 inhibitor, the decrease of albumin and
TCF1 expression and the reduction of b-catenin in the nucleus
occurred as with treatment with ethanol; however, expression of
cyclin D1 was not changed (data not shown).
Our data suggest that both ERK and WNT signaling pathways
are involved in the hepatic differentiation of hESC after treatment
with ethanol. However, the use of the Erk inhibitor appeared to be
most effective in replicating the same phenotypic changes as
occurred with ethanol treatment. The use of WNT inhibitor
resulted in some of the changes shown with ethanol treatment with
some differences. For example, use of the WNT inhibitor caused a
decrease of albumin, however, the WNT inhibitor did not reduce
the expression of cyclin D1. Our assumption is that the Erk
pathway was the major pathway regulating hepatocyte differen-
tiation with our culture conditions, and that the WNT pathway
was activated and synergistically involved in the hepatocyte
differentiation. Ethanol treatment inhibited Erk activation result-
ing in reduced activation of WNT/b-catenin pathway, which in
turn caused the down-regulation of the downstream targets, such
as TCF1 and cyclin D1. Another possibility would be that the
expression of cyclin D1 can be regulated by the ERK pathway
independent of b-catenin. We speculate that these results might
explain in part some of the elements of the pathophysiology of
alcohol-induced liver disease, for example the inhibition of
hepatocyte differentiation and proliferation.
In summary, our data demonstrated that ethanol negatively
regulate early hepatic differentiation of hESC-derived hepatic
progenitor cells, primarily through the inhibition of the MAPK/
ERK signaling pathway, and there was also a reduction of cyclin
D1 (Figure 6).
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